Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease (STIMULI)

Clinical Trial ID NCT02046733

PubWeight™ 6.57^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02046733

Top papers